Chimera Investment Corporation Ne.../ US16934Q5053 /
18.06.2024 22:10:00 | Изменение +0.05 | Объем сделки | Бид23:12:33 | Предложение23:12:33 | Максимум | Минимум |
---|---|---|---|---|---|---|
22.05USD | +0.23% | 36,812 Оборот: 464,848.16 |
21.29Величина цены спроса: 1,600 | 22.41Величина цены предложения: 800 | 22.05 | 21.93 |
GlobeNewswire
8:10
IDEX Biometrics secures repeat order for IDEX Access from AuthenTrend for new markets
GlobeNewswire
7:33
Vallourec extends its contract with the National Oil Company of Abu Dhabi and wins a new order
GlobeNewswire
7:30
OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of I...
GlobeNewswire
7:15
Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation
GlobeNewswire
7:00
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids a...
GlobeNewswire
7:00
Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids a...
GlobeNewswire
7:00
Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting
GlobeNewswire
7:00
Technip Energies awarded a significant contract for IOCL’s grassroots naphtha cracking unit at Parad...
Newsfile Corp
6:47
Monarch Equity Capital Berhad Signs MoA with DR.IP Strategy Partner of Universiti Malaya Centre for ...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница